Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $82.7200 (0.24%) ($80.6700 - $83.6200) on Thu. May. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 42 | Latest Price | $82.7200(0.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -4.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(57%) IWO(57%) IWM(56%) IWC(55%) IWN(54%) | Factors Impacting LGND price | LGND will decline at least -1.825% in a week (0% probabilities). VIXM(-19%) UUP(-18%) VXX(-16%) UNG(-7%) TBT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $89.02 | 5 Day Moving Average | $85.69(-3.47%) | 10 Day Moving Average | $84.12(-1.66%) | 20 Day Moving Average | $89.02(-7.08%) | To recent high | -31.4% | To recent low | 4.9% | Market Cap | $1.329b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |